Wenlong (Bill) Lian
About Wenlong (Bill) Lian
Wenlong (Bill) Lian is a Scientist II at Entrada Therapeutics with a PhD in Chemistry from The Ohio State University. He has published several journal papers, gained expertise in antiviral development, and possesses strong laboratory skills in protein purification and characterization.
Work at Entrada Therapeutics
Wenlong (Bill) Lian has been employed at Entrada Therapeutics as a Scientist II since 2018. His role involves research focused on drug discovery, particularly in the development of small molecule antiviral agents. Lian's work includes generating cell-permeable macrocyclic compounds aimed at inhibiting protein-protein interactions, which are relevant for treating cancers, inflammatory diseases, and diabetes. His contributions to the field are supported by his extensive background in laboratory techniques and drug development.
Education and Expertise
Wenlong Lian earned his Doctor of Philosophy (PhD) in Chemistry from The Ohio State University, where he studied from 2010 to 2015. He also holds a Bachelor's degree in Chemistry from 武汉大学, completed from 2006 to 2010. His educational background provides a strong foundation in chemical research, complemented by specialized training in virology and lab techniques. Lian has developed expertise in protein purification, characterization of protein-ligand binding affinity, and High-Throughput Screening during his postdoctoral research at Harvard Medical School.
Background
Wenlong Lian's academic journey began at 武汉大学, where he completed his Bachelor's degree in Chemistry. He then pursued advanced studies at The Ohio State University, culminating in a PhD in Chemistry. Following his doctoral studies, Lian worked as a Postdoctoral Research Fellow at Harvard Medical School from 2016 to 2018. His research during this time focused on small molecule antiviral development, enhancing his skills and knowledge in drug discovery and virology.
Achievements
Throughout his career, Wenlong Lian has contributed to the scientific community through several published journal papers, including two as first or co-first author in the Journal of the American Chemical Society (JACS). He holds a pending patent resulting from his PhD research, reflecting his innovative contributions to the field. Lian also has over three years of teaching experience as a teaching assistant, showcasing his proficiency in communicating complex scientific concepts.